Viewing Study NCT00565227


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-02-25 @ 6:53 PM
Study NCT ID: NCT00565227
Status: TERMINATED
Last Update Posted: 2016-12-02
First Post: 2007-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small-Cell Lung Carcinoma View
None Prostate Cancer View
None Bladder Cancer View
None Urothelial Carcinoma View
Keywords: